Inventors: Gaikwad Anil Bhanudas

Pharmacological intervention involves the utilization of α-Klotho in combination with an AT1 receptor blocker and a Sodium-Glucose Co-Transporter 2 (SGLT-2) inhibitor to manage diabetic kidney disease. This approach integrates the potential benefits of α-Klotho in conjunction with the known effects of AT1 receptor blockers and SGLT-2 inhibitors.